Oak Longevity vs IVIM Health: Price vs Program Structure
Oak Longevity vs IVIM Health: Quick verdict: Oak Longevity is geared to cost conscious patients seeking the lowest advertised starting prices and no subscription, while IVIM Health emphasizes a clinician-guided protocol and unusually strong third party ratings.
View Oak Longevity pricing and plans
How they differ at a glance
This comparison uses only supplied facts. Oak Longevity advertises semaglutide starting at $133/month and tirzepatide starting at $199/month with one flat price for all dosages, no subscriptions, free health coaching, and free shipping. IVIM Health advertises semaglutide at $75/month and tirzepatide at $133/month but notes a $74.99/month program fee and promotes a clinician-guided GLP-1 ID protocol and 4.9-star ratings on Google and Trustpilot.
Distinctive differences: price model, program structure, and trust signals
1. Price model and billing
Oak Longevity: semaglutide from $133/mo and tirzepatide from $199/mo. Oak says one flat price covers all dosages, billed monthly on a non recurring basis so you are not auto charged and choose to renew each month. Three month prescriptions are billed upfront and refunds are not available after physician approval and once medication has shipped.
IVIM Health: lists semaglutide at $75/mo and tirzepatide at $133/mo with an additional $74.99/mo program fee. IVIM also advertises a free month membership code GIFT75 and a no obligation free consultation valued at $75 to lower upfront cost. IVIM’s FAQ notes an ongoing rate of $174/month in some listings; the source frames first month and ongoing pricing separately.
2. Program structure and clinical process
Oak Longevity: The process is online with no video call required. Oak states licensed clinicians review cases and that the clinical review is asynchronous. Oak includes free health coaching with plans and free shipping. The source notes patients with BMI below 20 do not qualify for GLP 1 treatment and that compounded medications, when offered, are not FDA approved.
IVIM Health: Positions a clinician guided GLP 1 ID protocol with weekly dose adjustments and a structured optimization approach. IVIM publishes internal data and retrospective studies supporting its protocol claims, but those are not head to head trials. The source states compounded medications are prescribed only after consultation with an Ivím provider and are not FDA approved.
See IVIM Health program details
3. Third party ratings and outcomes claims
IVIM Health: The source highlights a 4.9 star rating on both Google and Trustpilot as a strong satisfaction signal. IVIM also cites internal and published retrospective observational studies in Obesity Pillars reporting larger average weight loss for patients following its protocol versus another published trial, with the source noting these are not randomized or head to head comparisons and results may vary.
Oak Longevity: The source emphasizes low prices, free coaching, and same day approval availability for qualifying patients. Oak states it has served 10,000+ patients according to the captured materials. Oak also warns compounded medications are not FDA approved.
Comparison table: Oak Longevity vs IVIM Health
| Criteria | Oak Longevity | IVIM Health |
|---|---|---|
| Starting price (semaglutide) | $133/mo | $75/mo |
| Starting price (tirzepatide) | $199/mo | $133/mo |
| Membership or program fee | No subscriptions or membership fees; non recurring billing | $74.99/mo program fee; free month with code GIFT75 |
| Clinical model | Asynchronous clinician review, no video call required, free health coaching | Clinician guided GLP 1 ID protocol with weekly adjustments and free consultation |
| Third party validation | 10,000+ patients served stated | 4.9 stars on Google and Trustpilot; published retrospective studies cited |
| Regulatory note | Compounded medications not FDA approved | Compounded medications not FDA approved |
Other practical differences
Availability and eligibility notes are supplied by each source. Oak states patients with BMI below 20 do not qualify for GLP 1 treatment and that treatment is available only when a licensed clinician determines it is medically appropriate. IVIM states compounded drugs are not available in all states and are prepared by independent licensed compounding pharmacies; prescriptions follow consultation with a provider.
Start IVIM Health consultation
Conclusion: Oak Longevity vs IVIM Health
Oak Longevity vs IVIM Health centers on a trade off between lower advertised flat pricing and a no subscription model at Oak, and IVIM’s clinician guided program with strong third party ratings and protocol claims. Oak is positioned as a lower cost option with asynchronous review and free coaching. IVIM is positioned as a program focused option with a clinician guided GLP 1 ID protocol, published retrospective studies, and dual 4.9 star reviews.
Choose Oak Longevity if you prioritize the lowest advertised starting prices, no subscription billing, free shipping, and asynchronous clinician review. Choose IVIM Health if you prioritize a clinician guided protocol, weekly dose optimization, published retrospective data and dual 4.9 star third party ratings.